The impact of obesity on breast cancer: A Retrospective review

Annals of Surgical Oncology

Volumn 19, Issue 9, 2012, Pages 3012-3018

  Haakinson, Danielle J ^a   Leeds, Steven G ^a   Dueck, Amylou C ^a   Gray, Richard J ^a   Wasif, Nabil ^a   Stucky, Chee Chee H ^a   Northfelt, Donald W ^a   Apsey, Heidi A ^a   Pockaj, Barbara ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST EXAMINATION; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MEDICAL RECORD REVIEW; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MAMMAPLASTY; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867404221     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2320-8     Document Type: Article

References (52)

1. Jernal A, Siegel R, Ward E, et al. Cancer Statistics 2008. CA Cancer J Clin. 2008;58:71-96.
2. Centers for Disease Control and Prevention. http://www.cdc.gov/obesity/ data/trends.html.
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States 2000. JAMA. 2004;291:1238-45.
4. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States 2000. JAMA. 2005;293:293-4.
5. Calle EE, Rodriguez C, Walker-Thurmod K, Thun MJ. Overweight, obesity, and mortality from cancer in a retrospectively studied cohort of U. S. adults. N Engl J Med. 2003;348:1625-38.
6. Guh DP, Zhang W, Bansback N, Amarsi Z, Birminghas CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
7. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216:28-43.
8. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev. 2003;4:157-73.
9. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134.
10. Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast. 2004;13:85-92.
11. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002;98:279-83.
12. Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111:329-42.
13. Carmichael AR. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG. 2006;113:1160-6.
14. Enger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early stage breast cancer. Arch Surg. 2004;139:954-8.
15. Griggs JJ, Sorbero ME, Lyman GH. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med. 2005;165:1267-73.
16. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat. 2008;109:389-95.
17. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev. 2004;5:153-65.
18. Cleary MP, Grossmann ME. Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150:2537-42.
19. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001;92:720-9.
20. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17:2078-86.
21. Vona-Davis L, Rose DP, Hazard H, et al. Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev. 2008;17:3319-24.
22. Feigelson HS, Patel AV, Teras LR, Gansler TS, Thun MJ, Calle EE. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006;107:12-21.
23. Gillespie EF, Sorbero ME, Hanauer DA, et al. Obesity and a ngiolymphatic invasion in primary breast cancer. Ann Surg Oncol. 2010;17:752-9.
24. Deglise C, Bouchardy C, Burri M, et al. Impact of obesity on the diagnosis and treatment of breast cancer. Breast Cancer Res Treat. 2010;120:185-93.
25. Suzuki R, Rylander-Rudqvist T, Ye W, Saji S, Wolk A. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer. 2006;119:1683-9.
26. Colditz GA, Rosner BA, Chen WY, Homes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96:218-28.
27. National Heart Lung and Blood Institute. http://nhlbisupport.com/bmi/.
28. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958; (June): 457-81.
29. Bouchardy C, Le MG, Hill C. Risk factors for breast cancer according to age at diagnosis in a French case-control study. J Clin Epidemiol. 1990;43:267-75.
30. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66:33-8.
31. Shields M, Carrol MD, Ogden CL. Adult obesity prevalence in Canada and the United States. NCHS Data Brief. 2011; (56): 1-8.
32. Pisano ED, Hendrick E, Gatsonis CA, et al. Diagnostic accuracy of digital vs film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246:376-83.
33. Cohen SS, Palmieri RT, Nyante SJ, et al. Obesity and screening for breast, cervical, and colorectal cancer in women. Cancer. 2008;112:1892-904.
34. Maruthur NM, Bolen S, Brancati FL, Clark JM. Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med. 2009;24:665-77.
35. Berclas G, Li S, Price KN, et al.; International Breast Cancer Study Group. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol. 2004;15:875-84.
36. Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany-a population based study. Br J Cancer. 2002;86:1034-40.
37. Olson CL, Schumaker HD, Yawn BP. Overweight women delay medical care. Arch Fam Med. 1994;3:888-92.
38. Fontaine KR, Faith MS, Allison DB, Cheskin LJ. Body weight and health care among women in the general population. Arch Fam Med. 1998;7:381-4.
39. Fiorio E, Mercanti A, Terrasi M, et al. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer. 2008;8:305.
40. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505-18.
41. Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the Nurses Health Study II. Endocr Relat Cancer. 2006;13:583-92.
42. Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist. 2008;13:16-24.
43. Goodwin PJ, Ligibel JA, Stambolic V. Metformin in breast cancer: time for action. J Clin Oncol. 2009;27:3271-3.
44. Ejlertsen B, Jensen MB, Rank F, et al. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst. 2009;101:729-35.
45. Dhakal HP, Naume B, Synnestvedt M, et al. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin Cancer Res. 2008;14:2341-50.
46. Garvey PB, Buchel EW, Pockaj BA, Gray RJ, Samson TD. The deep inferior epigastric perforator flap for breast reconstruction in overweight and obese patients. Plast Reconstr Surg. 2005;115:447-57.
47. Forouhi P, Dixon JM, Leonard RC, Chetty U. Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg. 1995;82:79-82.
48. Vilar-Compte D, Jacquemin B, Robles-Vidal C, Volkow P. Surgical site infections in breast surgery: case-control study. World J Surg. 2004;28:242-6.
49. McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008;121:1886-92.
50. Bozikov K, Arnez T, Hertl K, Arnez ZM. Fat necrosis in free DIEP flaps: incidence, risk, and predictor factors. Ann Plast Surg. 2009;63:138-42.
51. Spear SL, Ducic I, Cuoco F, Taylor N. Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction. Plast Reconstr Surg. 2007;119:788-95.
52. Litton JK, Gonzalez-Angulo AM, Warneke CL, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008;26:4072-7.